BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2017
View Archived Issues
New phase II trial investigates savolitinib for pulmonary sarcomatoid carcinoma in China
Read More
Takeda announces plans to spin off its Japan Consumer Healthcare Business Unit
Read More
Merck KGaA compares MSB-11022 to Humira in phase III trial for rheumatoid arthritis
Read More
Varlitinib receives orphan drug designation in Korea for biliary tract cancer
Read More
Novel HIV capsid inhibitors created at Gilead
Read More
Discuva and Roche extend collaboration to tackle antibiotic-resistant infections
Read More
SLCO2B1 polymorphism predicts poor response to abiraterone acetate in mCRPC patients
Read More
Neovacs and BioSense sign Chinese commercial license option agreement for IFN-alpha kinoid
Read More
Immuron announces completion of IMM-124E phase II NASH clinical trial recruitment
Read More
Encouraging results seen with pretomanid in NIX-TB Trial
Read More
Global HOPE pediatric hematology-oncology initiative launched in Africa
Read More
LAB282 drug discovery partnership awards first grants
Read More
Neurocognitive effects of cenicriviroc assessed in phase II study
Read More
European Commission grants conditional marketing authorization for Alecensa
Read More
Enigma Biomedical and McGill University sign research agreement for tau imaging agent MK-6240
Read More
FDA awards fast track designation to CMD-003
Read More
Phase II results for savolitinib show promise in MET-driven papillary renal cell carcinoma patients
Read More
Samumed identifies novel Wnt signaling and IL-6 production inhibitors
Read More
NantWorks/Nant Holdings patent thiosemicarbazone derivatives
Read More
Millennium Pharmaceuticals receives U.S. orphan designation for cancer candidate TAK-659
Read More
Nelfinavir named orphan drug in the U.S. for multiple myeloma
Read More
Novel TNF-alpha antagonists synthesized at Bristol-Myers Squibb
Read More
U.S. orphan drug status granted to decitabine plus tetrahydrouridine for thalassemia
Read More
Amgen discovers beta-secretase inhibitors
Read More
Vitae Pharmaceuticals discloses novel nuclear receptor ROR-gamma modulators
Read More
Raze Therapeutics presents novel MTHFD2 inhibitors
Read More